Skip to content

Frontlight ResearchEarly access

Trial site

Texas Oncology-Austin Central (Site 8003)

Austin, Texas 78731, United StatesNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Kidney cancer

Closed trials

Completed
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)
NCT03142334· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Texas Oncology-Austin Central (Site 8003): trial site – Frontlight Research